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ABSTRACT

Author: Tseng, Yu-Chung, MS
Institution: Purdue University
Degree Received: December 2017
Title: SWI/SNF Chromatin Remodeling Complexes in Porcine Embryos
Major Professor: Ryan Cabot

Gene expression is under precise regulation during early mammalian embryonic development.
Epigenetic modifications are a major aspect of studying gene expression. SWI/SNF chromatin
remodeling complexes are large multiprotein complexes, which can reposition nucleosomes and
alter transcription factor accessibility to DNA. Subunits of SWI/SNF chromatin remodeling
complexes play essential roles in development by guiding the complexes to specific loci. The aims
of this study were to 1) determine the function of ARID1A, a SWI/SNF chromatin remodeling
complex subunit during cleavage development in the porcine embryo and 2) determine the
intracellular localization of four SWI/SNF subunits, ARID1A, ARID2, BRD7, and SNF5, in
porcine embryos using an immunocytochemical approach. Our data show that ARID1A is essential
for early embryo development. Our results indicate that individual SWI/SNF subunits adopt unique
intracellular localization patterns at discrete developmental time points. Together, our data suggest
that the collection of SWI/SNF complexes within blastomeres of cleavage stage embryos may
differ at discrete developmental stages.
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CHAPTER 1. LITERATURE REVIEW

Embryo development in mammals is highly organized and regulated. Sexual reproduction includes
the events of sex determination, formation of gametes, fertilization and embryogenesis. Gene
activation and inactivation are global events that are critically important to embryo growth and
survival. Epigenetic modifications to both DNA and histone proteins play central roles in
regulating gene expression. Several studies have shown disruption of epigenetic marks in embryos
can lead to profound changes in embryo development. Studying the role of chromatin remodeling
during embryogenesis will provide better understanding of gene regulation in developing embryos.
1.1 Sex determination and sex differentiation
A gene called sex determining region of the y-chromosome (SRY) encodes a transcription factor
that functions as the testis determining factor (TDF) in most mammals.

SRY induces

differentiation of somatic supporting cell precursors into Sertoli cells; differentiation of Sertoli
cells leads to the enclosure of the primordial germ cells (PGCs) inside testis cords. In mice,
expression of Sry begins at embryonic day 10.5 and lasts for two days.

Studies indicate that

Wilm’s tumor suppressor gene 1 (WT1) serves a critical role in establishing the bipotential gonad
and testis development. The WT1 can activate SRY and Wt1-null mice die at mid-gestation and
lack gonadal tissue (Morrish and Sinclair, 2002).

SRY targets SOX9 and initiates the male-specific developmental pathway, while it represses the
female-specific developmental pathway. The two supporting cell types in the testis differentiate
and begin to generate important regulatory molecules that direct sexual differentiation after the
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testis begins to differentiate from the indifferent gonad (Gao et al, 2006).

The Leydig cells

produce testosterone, which promotes differentiation of the Wolffian ducts into the male tubular
reproductive tract (including the epididymis, vas deferens, seminal vesicles). The Sertoli cells
produce anti-Müllerian hormone (AMH), a hormone that represses the differentiation of the
Müllerian duct system into the female tubular reproductive tract (including the oviducts, uterus,
cervix and cranial vagina).

In the absence of testosterone and AMH, the Wolffian duct system

regresses and the Müllerian duct system differentiates in that above-mentioned portions of the
female tubular reproductive tract (Kobayashi and Behringer, 2003).
1.2 Formation of gametes
The primordial germ cells (PGCs) originate from a pluripotential population of cells in the
proximal epiblast (Lawson and Hage, 1994). The PGCs begin to migrate from the yolk sac at
embryonic day 7.5 in mice. During migration, the PGCs pass through the hindgut and arrive at
the indifferent gonad at embryonic day 12 (Hahnel and Eddy, 1986). Several signaling molecules
are known to serve critical roles during PGC migration, including bone morphogenic proteins 4
and 8 (BMP4 and BMP8, respectively) and interferon induced transmembrane protein 1 (IFITM1).
Published reports suggest that mouse PGCs are directed to the indifferent gonad by the c-kit
receptor, a transmembrane protein found on the PGCs.

This receptor binds to kit ligand, which

is expressed in somatic cells that lead to the indifferent gonad (Matsui et al., 1990). In addition,
the proliferation of PGCs during migration is promoted by signaling molecules including kit ligand
and c-kit (Keshet et al., 1991). Once PGCs arrive at the indifferent gonad, female germ cells
proliferate and differentiate into oogonia and initiate meiosis. These cells arrest at meiosis I and
are referred to as primary oocytes. Male germ cells divide mitotically for several rounds and then
enter a quiescent state where they are known as gonocytes (McLaren, 2003).
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1.3 Spermatogenesis
Spermatogenesis is the process by which the male gametes are created. The first phase of
spermatogenesis takes place within the seminiferous tubules of the testes and is referred to as
spermatocytogenesis.

The spermatogonia undergo a series of mitotic cell divisions during

spermatocytogenesis to ultimately form primary spermatocytes.

The primary spermatocytes

undergo the first meiotic cell division to yield secondary spermatocytes, which in turn complete
meiosis to yield haploid spermatids (Buehr, 1997).

Spermiogenesis begins as the spermatids undergo a series of morphological changes to yield
spermatozoa. During spermiogenesis, symmetric spermatids with oval nuclei and a large Golgi
apparatus with proacrosomal granules start to migrate toward one end. The nuclear chromatin
begins to condense and histones are replaced by protamines. The spermatid becomes polarized.
The nuclear and the Golgi/granules complex start to migrate to one side of spermatid. (Leblond
and Clermont, 1952). At the other end, the mitochondria gathered and the distal centriole begins
to form an axoneme. Axoneme is composed of a core of microtubules having a characteristic “9+2”
structure which is two central singlet microtubules are encircled by nine outer doublet
microtubules. Axoneme forms the majority of the tail section of spermatozoa. The remaining
cytoplasm and organelles, or residual bodies, are phagocytosed by Sertoli cells (Fawcett and
Phillips, 1969). Spermatogenesis ends with the fully formed, non-motile spermatozoa released
from the Sertoli cells. The spermatozoa start to float through the lumen of the seminiferous tubule
to the epididymis, where maturation of the spermatozoa occurs.
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1.4 Oogenesis
Oogenesis refers to the process by which oocytes are formed in the ovary. Unlike spermatogenesis
in males, oogenesis is initiated during fetal development. When colonizing the undifferentiated
gonadal ridge, PGCs initiate rapid mitosis for a short period, dividing to produce a few thousand
cells by embryonic day12-13 in the mouse. By embryonic day15 in the mouse, there are
approximately 18,000 germ cells in the ovary. PGCs upregulate a set of genes and undergo
differentiation. PGCs develop into oogonia by suppressing their pluripotency program (Tam and
Snow, 1981). During mid-to-late gestation, oogonia initiate meiosis, but arrest meiosis at the
diplotene stage of prophase I of the first meiotic division.

The meiotically arrested oocytes are

referred to as primary oocytes at this stage. Each individual primary oocyte is contained within an
ovarian structure called a follicle. During ovarian development, germ cells become progressively
enclosed within epithelial structures called "ovigerous cords" constituted by pregranulosa cells,
lined by a basement membrane. Ovigerous cords fragment into primordial follicles, which contain
an oocyte arrested at the first prophase of meiosis in each follicle, surrounded by a flattened layer
of somatic pre-granulosa cells (Channing et al. 1980).
1.5 Folliculogenesis
Folliculogenesis is the development of ovarian follicles, which are densely packed with granulosa
cells that surround the oocyte and outer layers of thecal cells. The whole process of folliculogenesis
includes primordial, primary, secondary, tertiary (antral), and, finally, the pre-ovulatory (Graafian)
follicle stages. Female mammals are born with primordial follicles that contain meiotically arrested
diploid primary oocytes. Before puberty, primordial follicles grow into primary follicles and
granulosa cells change morphology from flattened to cuboidal shape (Channing et al. 1980).
During the primary follicle stage, the zona pellucida starts to form. At secondary follicular stage,
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granulosa cells proliferate rapidly and the zona pellucida completely forms. In addition, theca cells
appear at this stage and cover the basement membrane. Theca cells are responsible for the
production of androstenedione which is the substrate for granulosa cells to convert to 17β-estradiol
by the enzyme aromatase. The estrogen (E2) produced by granulosa cells is necessary for
oogenesis. The last stage of folliculogenesis involves development of antral follicles or tertiary
follicles. At this stage, the growth of the follicle is hormone-dependent. FSH receptors on
granulosa cells are fully developed and the theca cells express receptors for LH. Without LH and
FSH, follicles undergo atresia and apoptosis would occur (diZerega and Hodgen, 1981).

Once a female reaches puberty, E2 produced by early antral follicles activates the surge center in
hypothalamus and ultimately leads to a surge of LH from the anterior pituitary. The surge of LH
leads to ovulation. The LH surge triggers primary oocytes to resume meiosis and complete the first
meiotic division to produce the first polar body and a secondary oocyte. The secondary oocyte is
arrested at the metaphase stage of the second meiotic division. Meiosis is only completed in
oocytes when they are fertilized. It is commonly recognized that the number of oocytes in female
processes is determined during fetal growth; no additional primary oocytes can be created after
birth. However, some studies have suggested that a stem cell population exists in the ovary that is
able to differentiate into oocytes (Leitch, et al. 2013).

Meiotic arrests are unique to oogenesis. The process is regulated by four major factors, including
M-phase promoting factor (MPF), cAMP, cytostatic factor (CSF) and the anaphase promoting
complex (APC) (Vermeiden and Zeilmaker, 1974). The MPF is a heterodimer composed of
cdk1/p34 and cyclin B. In the oogonium and GV-stage oocyte, cyclin B accumulates and binds to
cdk1. This leads to low activity of MPF and maintains the meiotic arrest in the primary oocyte. In
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addition, cAMP in the oocyte inhibits the activation (dephosphorylation of cdk1) of MPF (Byskov
et al. 1997).

At ovulation, the LH surge induces the production of hyaluronic acid, which terminates the gap
junctions between cumulus cells and the oocyte and leads to reduction of cAMP in the oocyte.
Cdk1 is dephosphorylated, MPF is activated and the oocyte resumes the cell cycle into metaphase
I (Tunquist and Maller, 2003). After ovulation, the oocyte completes meiosis I and enters meiosis
II. MPF is produced again (cdk1 binds to cyclin B) and CSF (including several protein kinases,
such as MAPK, MAPK kinase and p90rsk) inhibits APC, thus slowing the rate of cyclin B
destruction (Abrieu et al, 2001). The Ca2+ oscillation during fertilization activates calmodulindependent protein kinase II (CaMKII) and this leads to the activation of APC which induces cyclin
B ubiquitination and degradation. MPF is then inactivated and meiosis is resumed (Kosako et al,
1994).
1.6 Fertilization
The process of fertilization involves the fusion of female and male gametes to form a genetically
unique individual.

Sperm must undergo the process of capacitation prior to encountering an

oocyte. This process consists of a series of biochemical and physiological modifications to the
sperm cell that take place in the female reproductive tract and enable the sperm to undergo the
acrosome reaction once it encounters an oocyte.

Conceptually, capacitation involves the removal

of seminal plasma proteins from the acrosomal cap on the anterior portion of the sperm head and
activates PKA leading to an increase in actin polymerization, an essential process for the
development of hyperactivated motility (Lishko and Kirichok, 2010; Ickowicz et al. 2012).
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The zona pellucida is a transparent structure that surrounds the oocyte and protects the oocyte. It
is composed by different glycoproteins, including ZP1, ZP2, and ZP3. The ZP1 crosslinks ZP2
and ZP3. ZP2 and ZP3 are proposed to function as species-specific receptors for spermatozoa.
Studies have shown that the interaction between the sperm and zona pellucida of the oocyte is
species-specific (Hinsch et al, 1999). After a capacitated sperm encounters the zona pellucida, an
unknown receptor on the sperm cap surface binds to ZP3 and this triggers the acrosome reaction.
The acrosome reaction involves an opening of the acrosomal cap, which involves Ca2+ stimulated
exocytosis of hyaluronidase and acrosine from the acrosomal cap. The zona pellucida is then
digested by these enzymes allowing a space for the sperm to travel to the perivitelline space under
the zona pellucida so that the acrosome reacted sperm can initiate membrane fusion with the oocyte
cell membrane. (Austin, 1975).

Interaction between the plasma membranes of the sperm and oocyte requires several proteins.
Members of the disintegrin and metalloprotease proteins family (ADAMs), which include
ADAM1, 2, and 3 are the best characterized (Chen et al, 1999). The ADAM proteins on the sperm
membrane interact with integrins on oocyte membrane. In mouse, the fertilinβ(ADAM2) protein
binds the α6β1 integrin receptor on the oocyte plasma membrane (Evans et al, 1997). Studies have
also indicated the interaction between the sperm membrane protein, Izumo1 with the folate
receptor 4 (Folr4) and the protein Juno (Wassarman, 2014).
1.7 Blocks to polyspermy
As soon as the first sperm fuses with the oocyte, a change in membrane polarization occurs,
shifting the membrane potential to +20 mV, due to a small influx of sodium ions into the oocyte
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(Longo et al. 1986). This constitutes the first block to penetration of the oocyte by additional sperm
cells (a phenomenon known as polyspermy). Sperm cells cannot fuse with membranes when a
positive resting potential exists. It is not known whether the increased membrane potential is due
to the binding of the first sperm or the fusion of the first sperm with the egg (McCulloh and
Chambers 1992).

Sperm-oocyte fusion also leads to cortical granule exocytosis, or the cortical reaction. Cortical
granules are membrane bound organelles located in the cortex of unfertilized oocytes (Dandekar
and Talbot, 1992). Once the sperm and oocyte fuse, the oocyte releases calcium ions from the
endoplasmic reticulum, which leads to exocytosis of the cortical granules (Terasaki and Sardet,
1991). Cortical granules contents are released into the perivitelline space and alter the structure of
the zona pellucida proteins. The zona proteins (ZP2 and ZP3) are modified to become ZP2f and
ZP3f; these modified zona proteins are unable to interact with spermatozoa (Eisen and Reynolds,
1985).

A series of concurrent events take place after sperm-egg fusion that define a process referred to as
oocyte activation. Oocyte activation, conceptually, involves the release from metaphase II arrest
and the onset of embryonic development.

In mammals, oocytes are activated by a series of

intracellular Ca2+ oscillations following gamete fusion. It is known that a sperm-specific variant
of phospholipase C, phospholipase C-zeta is introduced into the oocyte after membrane fusion and
hydrolyzes the phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) into diacylglycerol
(DAG) and inositol 1,4,5-trisphosphate (IP3).

IP3 triggers the Ca2+ release from oocyte the

endoplasmic reticulum (Ozil, 1998). Ca2+ acts as a secondary messenger and binds to calmodulin
and activates calcium/calmodulin-dependent protein kinase II (CaMKII). CAMKII continues its
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cascade and activates anaphase-promoting complex/cyclosome (APC/C), which disassembles the
MPF (cdk1 and cyclin B complex) and ubiquitinates cyclin B1 and results in inactivation of
metaphase promoting factor (MPF). This resumes the meiotic cycle and results in the extrusion of
the second polar body to finish meiosis (Lorca et al, 1993).

The disulfide bonds in male chromosomal protamines are reduced by glutathione. This is known
as decondensation and results in the replacement of protamines by histones.

DNA synthesis

begins a few hours after fertilization. Male and female pronuclei move toward the center of the
zygote near the end of DNA replication and the nuclear envelopes break down. Chromosomes then
orientate on the metaphase spindle for mitosis. This combination of the two genomes is called
syngamy (Luthardt and Donahue, 1973).
1.8 Preimplantation embryo development
Cells must go through cell division to proliferate. For most cells, the stages of the cell cycle are
divided into two major phases: interphase and the mitotic (M) phase. Cells grow and make a copy
of their DNA during interphase and separate their DNA into two sets and divide into two new cells
at M phase. Interphase consists of three distinct phases: gap 1 (G1) phase, synthesis (S) phase, and
gap 2 (G2) phase. M phase can also be separated into two processes: karyokinesis, where the
chromosomes separate and cytokinesis, where the cytoplasm divides into two daughter cells. The
cell cycle is highly regulated by different proteins and mechanisms, such as cyclins, cyclindependent kinases (Cdk), c-Myc gene, MPF and APC/C (Sorensen and Wassarman, 1976).

After fertilization, the proximal sperm centriole is exposed to the ooplasm and the maternal
centrosome starts to form. The sperm aster, a structured microtubule, surrounds the centriole and
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guides the female pronucleus towards the male pronucleus. DNA synthesis is initiated during
migration of pronuclei. In mammals, the pronuclei never fuse together. The nuclear envelopes
breakdown after migration and the chromatin condenses into chromosome and mitosis progresses.
Diploid nuclei are formed at the 2-cell stage of embryogenesis. Embryos undergo holoblastic
cleavage and the cell division is asynchronous. In holoblastic division, each nuclear division is
accompanied by complete cytokinesis. During cleavage stages, the embryo undergoes mitosis and
increases the total cell number of the embryo but not the total cell volume. The first few mitotic
cell cycles during cleavage are longer than somatic cells (Wright and Longo, 1988). The first cell
cycle requires transformation of maternally and paternally derived chromatin into nuclei. Studies
shows the G2 and S phases are elongated (Howlett and Bolton, 1985). The second and third cell
division cycles have been observed with shorten G1 phase and S phase. They start almost
immediately after the previous mitosis is completed (Bolton et al, 1984).

The zygotic transcription activity is very low during early cleavage stages and the embryo relies
on maternal mRNA and proteins to control the first few cell divisions. Embryos enter the maternal
to zygotic transition (MZT), which includes zygotic genome activation (ZGA) and clearing of
maternal transcripts, at a species-specific time (Flach et al, 1982). The true mechanism initiating
this transition is not entirely clear, but studies show it relates to the ratio of cytoplasm and nuclei
in embryos (Lee et al, 2014). ZGA has been considered a landmark in terms of preimplantation
embryo development. Epigenetic marks are remodeled on a global scale during this transition.

The first cell differentiation event begins during compaction of the morula stage of development.
Proteins on the cell membrane of the blastomeres start to polarize and cell adhesion molecules
(CAM) bind to the cytoskeleton and the outer blastomeres begin to flatten. The result is a compact
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morula that possesses outer cells and inner cells. The organelles localize asymmetrically in outer
cells and they develop distinct apical and basolateral membrane domains. Tight junctions form
between adjacent cells in the morula, these cells tightly adhere to each other by cadherins and
catenins (Shirayoshi, 1983). In outer cells, the tight junction complexes function as a seal to limit
movement of extracellular molecules. Sodium ions accumulate in the extracellular space
surrounding the inner cells due to the action of sodium pumps on the basolateral side of the
polarized blastomeres. Water follows the sodium gradient to create a fluid filled space called a
blastocoel (Lo and Gilula, 1979).

At this stage, the embryo expands in size and cells differentiate into two distinct tissues: the outer
cells become the trophectoderm (TE) and inner cells turn into the inner cell mass (ICM) and the
embryo is at blastocyst stage. The TE will contribute to the chorion, the fetal part of the placenta,
and the ICM will develop into the fetus. As a blastocyst expands, the zona pellucida gets thinner;
the embryo sheds the zona by secreting a trypsin-like protease from trophoblast to digest the zona
(Sawada et al, 1990).
1.9 Epigenetic modifications
Epigenetic modifications include covalent and non-covalent changes to chromatin structure that
can alter gene activity, but do not involve changes in base pair sequence.
chromatin is referred to as the nucleosome.

The functional unit of

A nucleosome consists of 147 base pairs of nuclear

DNA that is wrapped around a histone octamer.

The N-terminal histone tails of the histone

proteins within the nucleosome extend into the nuclear lumen (Bird, 1986).
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There are several types of epigenetic modifications, many of which are considered heritable.
Examples of epigenetic modifications include DNA methylation, histone methylation, histone
acetylation, and chromatin remodeling.

Post-transcriptional regulation including non-coding

RNAs, micro RNAs (miRNA), and riboswitches, are known to regulate aspects of epigenetic
modifications.
1.10 DNA methylation
DNA methylation is one of the ways to modify gene expression without changing gene sequences.
This usually occurs at CpG islands. Methyltransferases (DNMT1, DNMT3a, and DNMT3b)
covalently attach a methyl group to the C5 position of cytosine residues. Gene transcription is
thereby repressed because the DNA recognition regions have been altered (Holliday and Pugh,
1975). DNA methylation establishes and maintains an inactive chromatin structure. DNA
methylation is dynamic during embryogenesis. Genomes from the oocyte and sperm are both
highly methylated, but within a few hours after fertilization the paternal genome is actively
demethylated. The maternal genome is passively demethylated during subsequent mitotic cell
divisions. The process of DNA demethylation is considered critical for successful embryo
development (Cedar and Razin, 1990). Several studies have shown that many factors can perturb
DNA methylation and demethylation in the mammalian embryo. These include heavy metals,
organic pollutants, maternal antibiotics, and tobacco usage (Pacchierotti and Spano, 2015).
1.11 Histone methylation
In most eukaryotic cells, DNA is wrapped around core histones and other chromosomal proteins
in the form of chromatin. The core histone tails are susceptible to a variety of covalent
modifications; one of these modification is methylation, which was first described in 1964. The
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methylation process is carried out by the histone methyltransferases (HMTs), which transfer
methyl groups from S-adenosyl methionine (SAM) onto amino acid residues of histones. The most
common methylated amino acids are lysine (K), arginine (R) and serine (S) residues, on the tails
of histone H3 and H4. Common marks of active sites of transcription include methylatyion at
H3K4, H3K48, and H3K79; common marks of transcriptionally inactive chromatin include
methylation at H3K9 and H3K27 (Murray, 1964). It has been reported that histone methylation
during embryogenesis is dynamic and critical for development (Li, 2002). Methylation at H3K4
increases dramatically in promoter regions after fertilization and during zygotic genome activation
(Liu et al, 2016). A mouse study revealed that G9a, a lysine histone methyltransferase, is required
for development; G9a deficient embryos show severe growth retardation and early lethality
(Tachibana et al, 2002).
1.12 Histone acetylation
Histone acetylation employs proteins collectively called histone acetyl transferases (HATs) to
acetylate the positively charged lysine residues on histone tails. Histone acetylation decreases the
affinity between histones and DNA so that the DNA can be released from the histone octomer to
decondense chromatin to make DNA more accessible to transcription factors. This process can be
reversed by histone deacetylases (HDACs) (Alfageme et al, 1974). Cell differentiation during early
embryogenesis requires alteration of many genes in a temporally-controlled manner; histone
acetylation and deacetylation are involved in the regulation of both local and global gene
expression (Huebert and Bernstein, 2005).

In histone acetylation studies, histone deacetylase inhibitor Trichostatin A (TSA) is commonly
used to increase the level of gene transcription. Several studies have shown that the TSA treatment
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improves the development capacity of embryos produced in vitro (Wang, 2007; Gonzales-Cope et
al, 2016; Ma and Schultz 2008; Zhao et al, 2010).
1.13 Non-covalent epigenetic modifications/ chromatin remodeling
Chromatin structure can also be manipulated by non-covalent mechanisms; this process is
generally referred to as chromatin remodeling and involves repositioning nucleosomes.
Nucleosomes are repositioned by a group of chromatin remodeling enzymes that utilize the energy
from hydrolysis of ATP to remove, reposition, and restructure the nucleosomes. There are several
types of chromatin remodeling complexes, examples include the switch/sucrose non-fermentable
(SWI/SNF), and the imitation SWI (ISWI) complexes. These remodeling complexes have an
SNF2-type ATPase core as their catalytic subunit, and several additional subunits to guide
complexes to a specific region of chromatin. These complexes are conserved among species and
serve essential roles in DNA repair, apoptosis, cell differentiation and others (Côté et al, 1994).
1.14 SWI/SNF chromatin remodeling complexes
The SWI/SNF chromatin remodeling complexes are large multi-protein complexes that consist of
9 to 12 subunits.

These subunits direct the complex and regulate its remodeling activities

including nucleosome sliding, nucleosome eviction, and selective removal of H2A/H2B dimers.
The complexes were discovered in yeast (Workman and Kingston, 1998) and they are highly
conserved among species.

Several SWI/SNF complexes have been studied in human, including BRM-associated factor
complex (BAF or SWI/SNF-A), polybromo-associated BAF complex (PBAF or SWI/SNF-B),
nucleosomal methylation activation complex (NUMAC), and WSTF including nucleosome
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assembly complex (WINAC). These complexes contain either BRM (Brahma / SMARCA2) or
brahma-related gene 1 (BRG1 or SMARCA4) as their catalytic subunit.

Studies have shown that deletions of components of SWI/SNF complexes can lead to
preimplantation lethality.

Deletions studies in mice has shown that knockout mice that lack

specific SWI/SNF subunits can also affect differentiated cells (e.g., neurons, hematopoietic cells,
and germ cells) (Chi et al., 2003; Griffin et al., 2008; Wang et al., 2012).

There is evidence to suggest that BRG1 and BRM serve different roles during the cell cycle.
Studies have shown that Brg1 expression levels remain unchanged during cleavage development
through the blastocyst stage development, while Brm transcription is up-regulated during this
window of development (Klochendler-Yeivin et al, 2000). BRG1 also appears to regulate zygotic
genome activation in mammalian embryos (Bultman et al, 2006). Alterations in BRG1 expression
can alter the methylation status of H3K4.

This has been shown to affect porcine embryo

development and subsequently change the expression levels of other chromatin remodeling
proteins (Glanzner et al, 2017). BRG1 knockout embryos fail to progress further than the
blastocyst stage, while BRM knockouts have been reported to possess only a mild overgrowth
phenotype as adults (Bultman et al. 2000; Reyes et al. 1998).

BRG1 has been shown to be

essential for muscle differentiation, while BRM is necessary for muscle cell cycle arrest (Albini et
al, 2015).

SWI/SNF chromatin remodeling complexes are also a focused subject in tumor studies. Recent
studies have indicated that cancer development correlates with epigenetic alterations. Mutations
that inactivate or down regulate SWI/SNF subunits are found in many tumor cells; they are
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therefore considered necessary to prevent tumor formation (Hohmann and Vakoc, 2014). Rhabdoid
tumor is an aggressive pediatric malignancy that arises in the kidney, brain, and soft tissues;
Rhabdoid tumor is related to complete loss of SNF5/SMARCB1. Studies show that the SWI/SNF
complexes can directly interact with Myc, a multifunctional, nuclear phosphoprotein that plays a
role in cell cycle progression, apoptosis and cellular transformation. This up-regulated oncogene
is found in tumor cells; it has also been shown to cooperate with P53 pathway to regulate VEGFR2
in breast cancer cells (Pfister et al, 2015; Wang et al, 2014)
1.15 In vitro embryo production
Assisted reproduction technologies (ARTs) are used in animals and humans to address
reproductive efficiency and infertility. ART in swine was first reported in 1974 when Motlik and
Fulka first matured porcine oocytes to the MII in vitro (Motlìk and Fulka, 1974). Iritani and
colleagues reported in vitro fertilization from in vitro matured porcine oocytes in 1978 (Iritani et
al, 1978). In 1988, in vitro fertilization was performed in the domestic pig using frozen semen
(Nagai et al, 1988); the first report of blastocyst stage porcine embryos developing from in vitro
fertilized oocytes came in 1989 (Mattioli et al 1989). The first piglet produced by transferring in
vitro produced 2-cell embryos to a recipient was reported by Yoshida et al. in 1993 (Yoshida et al,
1993).
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CHAPTER 2: ARID1A, A COMPONENT OF SWI/SNF CHROMATIN
REMODELING COMPLEXES, IS REQUIRED FOR PORCINE EMBRYO
DEVELOPMENT

2.1 Abstract
Mammalian embryos undergo a dramatic amount of epigenetic remodeling that can have a
profound impact on both gene transcription and overall embryo developmental competence. The
SWI/SNF family of chromatin remodeling complexes repositions nucleosomes and alters
transcription factor accessibility. SWI/SNF complexes are large, multi-protein complexes that
have an SNF2-type ATPase (either BRG1 or BRM) as their core catalytic subunit as well as a
variable array of other subunits that direct the complex to particular loci.

Little is known about

the identity of specific SWI/SNF complexes that serve regulatory roles during cleavage
development. ARID1A, one of the SWI/SNF complex subunits, has been shown to affect histone
methylation. The objective of this study was to determine the transcript abundance of ARID1A
transcript in porcine oocytes and cleavage stage embryos and determine the developmental
requirements of ARID1A. We found ARID1A transcript levels were significantly reduced in 4cell stage porcine embryos, as compared to levels in GV-stage oocytes.

We hypothesized that

ARID1A would be required for porcine cleavage embryo development. To test our hypothesis, in
vitro matured and fertilized porcine oocytes were injected with double-stranded interfering RNAs
that target ARID1A and cultured for seven days to determine cell numbers. Embryos injected
with ARID1A-interfering RNAs had significantly fewer cells than their respective control groups
(P < 0.001).
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2.2 Introduction
A dramatic amount of epigenetic remodeling takes places during the first week of mammalian
embryo development.

These epigenetic changes are dynamic and impact gene expression and

embryo developmental potential.

Epigenetic changes that impact chromatin structure and

transcription must be properly coordinated to ensure proper embryo development.

A number of different epigenetic marks have been shown to be remodeled during cleavage
development. For examples, trimethylation status of the lysine 27 residue of the tail of histone
protein H3 (trimethyl H3K27) is a covalent epigenetic mark that gradually decreases in abundance
during the early cleavage divisions in both bovine and porcine embryos (Ross et al, 2008; Park et
al, 2009). Non-covalent changes to chromatin structure represent another class of epigenetic
regulation.

Here, chromatin-remodeling complexes utilize the energy from ATP hydrolysis to

reposition and restructure nucleosomes (Bartholomew et al, 2014).

Multiple ATP-dependent

chromatin remodeling complexes have been characterized. The SWI/SNF (SWItch/Sucrose NonFermentable) complexes have been shown to play a critical role during mammalian cleavage
development (Klochendler-Yeivin et al, 2000; Wang et al, 2010).

The SWI/SNF chromatin remodeling complexes are large multi-component complexes that
contain either BRM (Brahma / SMARCA2) or BRG1 (Brahma-related Gene 1/ SMARCA4).
BRG1 and BRM are ATPases and serve as the catalytic subunit of all SWI/SNF complexes. A
series of BRG1 Associated Factors (BAFs) complex with either BRM or BRG1 to create a
functional SWI/SNF chromatin remodeling complex. The combination of BAFs that associate
with the catalytic subunit determine the identity of a given SWI/SNF chromatin remodeling
complex and dictate the sites where that complex will act (Clapier and Cairns, 2009).
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Multiple pieces of evidence suggest that although distinct SWI/SNF complexes are not
functionally redundant, SWI/SNF-mediated chromatin remodeling is critical for mammalian
embryo development. In mice, BRG1 knockout embryos fail to progress further than the blastocyst
stage (Bultman et al, 2000), while BRM null embryos develop to term and only show a mild
overgrowth phenotype as adults (Reyes et al, 1998). BRG1 appears to regulate zygotic genome
activation in mammalian embryos (Bultman et al, 2006); studies also suggest BRG1 serves a
critical role in trophectoderm development of mouse embryos (Wang et al, 2010).
BRG1 physically cooperates with CHD4 (chromodomain helicase DNA binding protein 4), a
protein that belongs to the SNF2/RAD54 helicase family and functions as epigenetic
transcriptional repressor (Singh and Archer, 2014). BRG1 knockout mice show a reduction in
trimethyl H3K27, which leads to increased apoptosis and growth retardation (Singh et al, 2016).
Alterations in BRG1 expression levels can influence the methylation status of the lysine 4 residue
of histone protein H3 (H3K4) (Glanzner et al, 2017), negatively affect porcine embryo
development, and subsequently change the expression levels of other chromatin remodeling
proteins (Magnani and Cabot, 2009).

BAFs have been shown to have unique functions within SWI/SNF complexes. BAF170, BAF155
and SNF5 (INI1/BAF47) appear to be conserved subunits in all SWI/SNF complexes and support
the remodeling activity of the complex (Phelan et al, 1999). Down regulation of these subunits
results in cell cycle arrest and interrupts gene expression (Phelan et al, 1999). BAF45A and
BAF53A appear to be required for neural stem and progenitor cells proliferation (Lessard et al,
2007). The expression levels of BAF155 and BAF170 differ between undifferentiated and
differentiated mouse ES cells. The level of BAF155 is significantly higher than BAF170 in
undifferentiated mouse ES cells. BAF155 levels decrease significantly when ES cells undergo
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differentiation (Yan et al, 2008).

ARID1A and ARID2 are two large, mutually exclusive BAF subunits found in SWI/SNF
complexes (Lemon et al, 2001). The expression levels of ARID1A, ARID1B, and
SNF2/SMARCA2 are upregulated in rhesus monkey blastocyst stage embryos, which suggests
that these subunits are related to cell lineage commitment (Zheng et al, 2004). ARID1A cooperates
with elongin C, cullin 2, and Roc1 to form an E3 ubiquitin ligase, which becomes an adapter for
lysine 120 of histone 2B (H2B K120) to be remodeled by the SWI/SNF complex (Xi et al, 2008).
ARID1A also plays a role in the pluripotency of ES cells in mice; ARID1A knockout mice fail to
finish gastrulation (Wang et al, 2004; Gao et al, 2008; Li et al, 2010).

While SWI/SNF-mediated chromatin remodeling is required for mammalian embryo development,
it is unclear which SWI/SNF complexes remodel chromatin during cleavage development.

To

test the hypothesis that ARID1A is required for cleavage stage development in the porcine embryo,
we quantified the changes in ARID1A transcript abundance in porcine oocytes and cleavage stage
embryos and performed an RNAinterference assay to determine the developmental requirements
of ARID1A in porcine cleavage stage embryos.

Our results show ARID1A transcripts are in

greatest abundance in germinal vesicle (GV) stage oocytes and are decreased significantly in 4cell stage porcine embryos.
cleavage development.

We also find that knockdown of ARID1A results in impaired
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2.3 Materials and Methods
Oocyte collection
All chemicals were obtained from Sigma Chemical Company (St. Louis, MO) unless stated
otherwise. Porcine (Sus scrofa) ovaries of prepubertal gilts were collected from a local abattoir,
rinsed in 37°C saline, and transported to the laboratory in an insulated container. Cumulus-oocytecomplexes (COCs) and follicular fluid were manually aspirated from antral follicles that were 3–
5 mm in diameter. Follicular fluid containing the COCs was held at 39 °C and allowed to settle
by gravity. COCs were resuspended in HEPES-buffered medium containing 0.01% polyvinyl
alcohol (PVA) (Abeydeera et al, 1998). COCs with multiple layers of intact cumulus cells were
selected for the experiments. For germinal vesicle (GV)-stage oocytes used in PCR studies and
microinjection, COCs were vortexed in 0.1% hyaluronidase in HEPES-buffered medium for 9
minutes to remove the cumulus cells.

In vitro maturation
COCs (90-120) were matured in 500 µl of tissue culture medium 199 (TCM-199; Gibco BRL,
Grand island, NY) containing 10 ng/ml epidermal growth factor, 0.57 mM cysteine, 0.5 IU/ml
FSH, and 0.5 IU/ml LH. COCs were matured for 42 hours at 39°C and 5% CO2 in air, 100%
humidity (Abeydeera et al, 1998). Matured COCs were then vortexed in 0.1% hyaluronidase in
HEPES-buffered medium containing 0.01% PVA for 4 minutes to remove the cumulus cells.

Parthenogenesis
Denuded MII stage oocytes were placed between two platinum electrodes on an Electrocell
chamber and covered by activation medium (300mM Mannitol, 0.1 mM CaCl2, 0.1 mM MgSO4,
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0.5mM HEPES, 0.01% BSA). Two DC pulses of 1.2 kV/cm for 30 sec were provided by a BTX
electro-cell Manipulator 200 (BTX, San Diego, CA) to artificially activate oocytes.

In vitro fertilization and embryo culture
Thirty matured and denuded oocytes were placed in 100 µl of modified Tris-buffered medium
(mTBM) and fertilized following an established protocol (Abeydeera et al, 1997), using fresh,
extended boar semen. Briefly, semen was collected from a boar of proven fertility at the Purdue
Animal Sciences Research and Education Center and extended in Modena Boar Semen Extender
(Swine Genetics International, USA) and stored at 17.5°C for up to three days. Before fertilization,
1 ml of extended semen was mixed with 9 ml Dulbecco’s Phosphate Buffered Saline containing 1
mg/ml BSA (DPBS) and centrifuged at 1000xg, 25°C, for four minutes; sperm washing was
repeated a total of three times. After three washes, the sperm pellet was resuspended in mTBM
and added to oocytes at a final concentration of 5×105 spermatozoa/ml; gametes were co-incubated
for 5 hours at 39°C and 5% CO2. Embryos were cultured in Porcine Zygote Medium 3 (PZM3)
supplemented with 3 mg/ml fatty acid-free BSA (Yoshioka et al, 2002) at 39°C, 5% CO2 and 100%
humidity for 12 hours, 48 hours and 7 days in order to collect pronuclear, 4-cell and blastocyst
stage embryos, respectively.

RNA isolation, reverse transcription
RNA was isolated from porcine oocytes and embryos using the DYNABEADS reagent (Invitrogen
Corporation, Carlsbad, CA, USA) according to the manufacturer’s protocol.

Briefly, pools of

100-150 GV-stage porcine oocytes, 4-cell stage embryos, and blastocyst stage porcine embryos
were washed in HEPES-buffered medium three times and placed in 100 l DYNABEADS lysis
buffer.

Lysed cells were stored at -80°C until further processing (Lonergan et al, 2003).
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Immediately after mRNA isolation, reverse transcription (RT) was performed in a 20 l reaction
with the iScript kit (Bio-Rad, Hercules, CA, USA) according to the manufacturer’s protocol.

Quantitative PCR
Oligonucleotide primers were designed to amplify ARID1A using sequence data available in
GenBank (XM_013988788.1). Oligonucleotide primers used in this experiment were as follow:
ARID1A

forward:

5’-

AGCCCAGAGATGATGGGTCT;

and

reverse

5’-

TCCTCCGTGAAGGCCAGATA, product size 209 nucleotides. The ARID1A PCR products were
cloned into pENTRTM/SD/D-TOPO vector (Invitrogen, Carlsbad, CA, USA) and sequenced to
confirm their identities. ARID1A primers were then used to construct standard curves. The
amplification efficiency of the primer set was determined to validate our assay. The abundance of
ARID1A was determined relative to a housekeeping gene, YWHAG. YWHAG (GenBank accession
number CO94522) primers were: forward: 5’-TCCATCACTGAGGAAAACTGCTAA; and
reverse 5’-TTTTTCCAACTCCGTGTTTCTCTA, product size 130 nucleotides (Whitworth et al.
2005).

A master mix containing 12.5 l of SybrGreen Master mix (Bio-Rad), 5l of 1M forward primer,
5l of 1M reverse primer and 2.5l of each RT reaction was prepared. For each replicate, cDNA
from one pool of embryos or oocytes was separated into two groups, one to amplify YWHAG and
one to amplify ARID1A; all reactions were performed within the same PCR run. Reactions for each
gene were run in duplicates and three biological replicates were performed in total. The MyiQ
single color real-time thermal cycler (Bio-Rad) was employed and the following program was used:
5’ initial denaturation at 94°C, followed by 45 cycles of 5 seconds at 94°C, 30 seconds at 60°C,
and 30 seconds at 72°C. A melting curve was produced to verify individual transcripts.
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Quantification of transcript levels
The comparative threshold cycle (Ct) method was employed here to quantify the relative
transcription level of ARID1A. The abundance of ARID1A was compared to the transcript level of
YWHAG; YWHAG has previously been shown to maintain a constant transcript level through
preimplantation development in porcine embryos (Whitworth et al. 2005). The Ct value, the point
where the PCR product rises above background during the log-linear phase, was determined for
each reaction. The Ct value of ARID1A was subtracted from the Ct of YWHAG and the change in
Ct (△Ct) was obtained. The GV stage △Ct was used as the calibrator and used subsequently to
obtain △△Ct values. The transcript level of ARID1A in each stage of embryos was calculated
using the equation 2-△△CT (Magnani and Cabot, 2008).

RNA interference
The BLOCK-iT™ RNAi Designer (Invitrogen) was employed to design our siRNA against
ARID1A based on the full-length porcine ARID1A open reading frame. Custom made StealthTM
RNAi nucleotides targeting porcine ARID1A were 5’- CGGACAGCAUCAUGCAUCCUUCUAU
and nonsense StealthTM RNAi nucleotides were 5’- CGGCGACUAGUAUACUCCCUACUAU.
The nonsense siRNA was designed so it was not complimentary to ARID1A while maintaining the
same molecular weight as ARID1A siRNA. StealthTM RNAi nucleotides were diluted in RNasefree water to a concentration of 1 µM in 5µl aliquots and stored at –20°C.

Microinjection
Presumptive porcine zygotes were vortexed in 0.1% hyaluronidase in HEPES-buffered medium
for 4 minutes to remove sperm immediately after gamete co-incubation. Presumptive zygotes
were then divided into three groups in HEPES-buffered medium containing 3mg/ml BSA. The
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three groups were as follows: ARID1A siRNA injected, control siRNA injected, and non-injection
controls. Injection needles were loaded with 5l of 1M siRNA; injection capillary pipettes were
then connected to an Eppendorf Femtojet microinjector (Eppendorf, Hauppauge, NY, USA).
Embryos that lysed immediately after injection were removed and excluded from analysis. After
injection, surviving embryos were placed in PZM3 embryo culture medium and cultured for seven
days. On day 7, embryos were subject to immunocytochemical staining and nuclei were counted
using confocal microscopy.

For knockdown effect validation, porcine GV stage oocytes were vortexed in 0.1% hyaluronidase
in HEPES-buffered medium for 8 minutes to remove cumulus cells and followed by the same
microinjection process and treatment as presumptive zygotes. After injection, surviving oocytes
were placed in mTBM maturation medium for 40 hours and subject to RNA isolation.

Efficiency of RNAi-mediated knockdown
To determine the knockdown effect of ARID1A siRNA, denuded GV-stage oocytes were assigned
to one of three treatment groups: ARID1A siRNA injected, nonsense siRNA injected, and noninjection controls. After microinjection, all oocytes in their respective treatment groups were
placed in in vitro maturation medium for 40 hours. mRNA was then isolated from intact oocytes
from each treatment and RT-PCR was performed on each mRNA sample.

Immunocytochemical staining
Porcine embryos cultured for 7 days were collected and washed with HEPES-buffered medium
three times and fixed in 3.7% paraformaldehyde at 4°C for 1 hour. Following three washes in
phosphate-buffered saline (PBS) containing 0.1% Tween-20 (PBST), fixed embryos were
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permeabilized in 1% Triton X-100 in PBS for 1 hour and incubated in blocking solution (0.1 M
glycine, 1% goat serum, 0.01% Triton X-100, 1% powdered nonfat dry milk, 0.5% BSA and 0.02%
sodium azide in PBS) overnight (12-18 hours) (Prather and Rickords 1992). Embryos then were
subjected to incubation with primary antibody against ARID1A (Abcam, Cambridge, MA, USA,
cat# ab182560), diluted 1: 500 in PBST at 4°C overnight. Embryos were then washed three times
in PBST (15 min per wash) and subsequently incubated with secondary antibody (goat-anti-rabbitIgG, FITC-conjugated, 1:500) in PBST at 4°C overnight. After three 15 minute washes in PBST,
all embryos were subsequently stained with Hoechst 33342 (5 µg/ml) for 20 minutes and mounted
on slides in Vectashield (Vector Laboratories, Inc., Burlingame, CA, USA); slides were sealed with
nail polish. Samples were examined on a confocal microscope (inverted Nikon A1R_MP
microscope) including de-scanned detectors and laser lines at 408 nm (Hoechst) and 488 nm
(FITC).

Statistical analysis
One way analysis of variance was employed for quantitative PCR data. The 2-△△CT values were
imported into Statistical Analysis Software (SAS, SAS Institute, Cary, NC, USA) and analyzed
with one-way ANOVA. Differences were compared using Tukey’s multiple comparison post-test.
The embryo stages and replicates were considered as the main factors and a p-value< 0.05 was
considered significant. For the microinjection experiment, two-way ANOVA model was employed
and a multiple comparison between replicates and treatments test was performed in SAS.
2.4 Results
Expression of ARID1A in porcine oocytes and cleavage stage embryos ARIDA transcripts were
detected in porcine GV-stage oocytes as well as 4-cell and blastocyst stage embryos produced by
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in vitro fertilization and parthenogenesis. The highest level of ARID1A transcripts was found in
GV-stage oocytes, as compared to 4-cell and blastocyst stage embryos produced either by
fertilization or parthenogenetic activation (GV vs 4C and BL, p<0.05).

ARID1A transcript

abundance was reduced 11.08 and 1.928 fold in parthenogenetic 4-cell stage and blastocyst stage
embryos, respectively and reduced 13.05 and 1.195 fold in embryos produced by fertilization at
the 4-cell stage and blastocyst stage, respectively.

No significant difference in ARID1A transcript

abundance was found between 4-cell stage and blastocyst stage embryos (either those produced
by fertilization or parthenogenetic activation; Figure 1).

Efficiency of ARID1A knockdown
GV-stage porcine oocytes were assigned to one of three treatment groups immediately after
cumulus cell removal. In the first treatment group (ARID1A RNAi), denuded GV-stage oocytes
were injected with interfering RNAs that targeted ARID1A; in the second group (control RNAi),
denuded GV-stage oocytes were injected with interfering RNAs containing a scrambled targeting
sequence; and the third group (non-injected) consisted of non-injected, denuded GV-stage oocytes.
Forty hours after treatment, RNA was isolated from each treatment group and subsequently cDNA
was amplified by PCR to determine the relative transcript abundance of ARID1A. Our results
revealed a robust reduction in ARID1A transcript abundance in the ARID1A RNAi treatment group
(Figure 2).

Reduction in embryo developmental potential upon ARID1A knockdown
Fertilized oocytes were assigned to one of three treatment groups five hours after gamete mixing.
In the first treatment group (ARID1A RNAi), presumptive zygotes were injected with interfering
RNAs that targeted ARID1A; in the second group (control RNAi), presumptive zygotes were

36
injected with interfering RNAs containimg a scrambled targeting sequence; and the third group
(non-injected) consisted of non-injected presumptive zygotes. Our results showed a significant
reduction in total cell number in the ARID1A RNAi treatment group, as compared to the two
control treatment groups (2.03 nuclei per embryo vs 4.95 and 5.58 nuclei per embryo for control
RNAi and non-injected groups, respectively, p<0.001; Table 1).

In addition, we found no

embryos in the ARID1A RNAi group formed morphological blastocysts, while both control groups
contained morphological blastocysts (0% vs 5.8% and 6.7% for control RNAi and non-injected
groups, respectively, p<0.05). Moreover, only 2% of embryos in the ARID1A RNAi treatment
group developed beyond the 8-cell stage, while 17.94% and 19.44% of embryos in control RNAi
injected

and

non-injected

embryos

processed

beyond

8-cell

stage

(Table

1).

Immunocytochemical analysis of embryos revealed a marked reduction in ARID1A protein in
embryos from the ARID1A RNAi group, as compared to our two control treatments (Figure 3);
embryos from the control RNAi and non-injected groups possessed clear nuclear localization of
ARID1A.
2.5 Discussion
Chromatin remodeling directed by the multi-subunit SWI/SNF chromatin remodeling complexes
serves a critical role in embryogenesis, affecting pivotal events of zygotic genome activation and
trophectoderm differentiation (Bultman et al, 2006; Wang et al, 2010). Determining the expression
level and functional roles of chromatin remodeling subunits is central to understanding how
epigenetic modifications are established and remodeled during this critical developmental window
(Okada and Yamaguchi, 2017).

ARID1A (BAF250A) is a unique subunit of the SWI/SNF

chromatin remodeling complexes that is highly associated with cell cycle regulation and cell
pluripotency (Kwon et al, 1994). Studies show that ARID1A participates in the repair of DNA
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double strand breaks and sustains the function of ART, a member of the phosphatidylinositol 3kinase-like kinase family that is involved in DNA repair and cell cycle check points (Watanabe et
al, 2014).

In terms of cell proliferation and differentiation, ARID1A expression modulates the

SWI/SNF complex occupancy at specific loci of gene regulatory regions for cell differentiation,
such as P19 in cardiac cells (Lei et al, 2015).

In this study, we have determined the expression pattern of ARID1A in cleavage stage porcine
embryos produced by both parthenogenesis and in vitro fertilization. ARID1A is expressed in GV
stage porcine oocytes and its transcript levels display a significant decline in 4-cell stage embryos.
This expression pattern is similar to the findings reported in mouse and rhesus monkey oocytes
and embryos (Zheng et al, 2004; Gao et al, 2008).

The essential role of ARID1A during cleavage development has been tested through an RNA
interference assay.

Our finding that ARID1A is localized in nuclei in 4-cell stage porcine

embryos supports the hypothesis that ARID1A-containing SWI/SNF chromatin remodeling
complexes play a crucial role during cleavage development. Our results suggest that loss of
ARID1A, or a disruption in its expression, leads to changes in chromatin structure at poised genes.

In mouse studies, ARID1A is required for complete development of the germ layers; depletion of
ARID1A in mouse embryos results in developmental arrest at the blastocyst stage (Gao et al, 2008).
Similar to mouse embryos, ARID1A knockdown in porcine embryos decreases developmental
competence. Moreover, ARID1A knockdown is lethal to porcine embryos, evidence by the fact
that none of our ARID1A-RNAi treatment embryos developed to the blastocyst stage. Collectively,
our results suggest that ARID1A may be necessary to undergo complete zygotic genome activation.
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In conclusion, ARID1A can be detected in GV oocytes and the expression level drops significantly
at 4-cell stage and increased in blastocyst stage embryos. The expression pattern is similar across
several species, which include pigs and mice. The data discussed above strongly support our
hypothesis that ARID1A is required for porcine cleavage stage embryo development.

Studies in

human and mice indicate that ARID1A/BAF250A/P27 is involved in the trimethylation status of
histone H2BK120, H3K4, H3K4 and H3K27, epigenetic marks that are critical in cell
differentiation and cell proliferation, two major events occurring during blastocyst formation
(Zheng et al, 2004; Gao et al, 2008; Shen et al, 2015). Precisely how ARID1A directs the SWI/SNF
complexes to specific loci and what genes are misregulated and ultimately lead to embryo
developmental arrest remains to be determined.
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CHAPTER 3: ARID1A, ARID2, SNF5 AND BRD7 ADOPT UNIQUE
INTRACELLULAR LOCALIZATION PATTERNS IN PORCINE
OOCYTES AND EMBRYOS

3.1 Abstract
Chromatin remodeling is a way to change the epigenetic state. SWI/SNF complexes are multiprotein complexes that possess an SNF2-type ATPase as their catalytic subunit. SWI/SNF
complexes reposition nucleosomes on a chromatin template by utilizing the energy from ATP
hydrolysis and therefore allow transcript proteins and co-factors to access genomic DNA. BRG1
associate factors (BAFs) which are critical components in SWI/SNF complexes direct the
remodeling complex to specific loci and function to activate or repress transcription.

The aim of this study was to justify that in vitro embryo manipulations had influences on SWI/SNF
subunits which had the potential to disrupt the epigenetic state and therefore reduced
developmental potential of in vitro embryos. We had localized BAFs (ARID1A, ARID2, BRD7,
and SNF5) that were highly associated with cell division and cell differentiation in cleavage stage
embryos. Our results show that in GV stage oocytes, ARID1A was evenly distributed in cytoplasm
and moved into nuclei as cleavage progressed; ARID2 was tightly associated with chromatin in
GV oocytes and have nuclear localization in 4-cell and blastocyst embryos; SNF5 was evenly
distributed in cytoplasm in GV stage oocytes and become nuclear enrichment in both 4-cell and
blastocyst stage embryos; BRD7 show different patterns. BRD7 was evenly distributed in
cytoplasm in GV oocytes but decreased abundance in nuclei as the cleavage progressed. Our
results showed there were no significant differences in localization or abundance of SNF5, BRD7,
ARID1A and ARID2 in embryos produced in vivo and in vitro. More sensitive approach could be
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employed for further investigation.
3.2 Introduction
It remains unknown why offspring born from assisted reproductive technology (ART) suffer from
reduced developmental potential and an increased risk for developing diseases that have an
epigenetic basis as epigenetic modifications are highly regulated during the first week of
mammalian embryo development (Chang et al, 2005). These epigenetic changes are dynamic and
impact gene expression and embryo developmental potential.

Epigenetic changes have a

profound impact on chromatin structure and gene expression. Epigenetic modifications must be
properly coordinated to ensure proper embryo development. There are several epigenetic
modifications including DNA methylation, histone methylation and histone acetylation. Posttranscriptional regulation including non-coding RNAs, micro RNAs (miRNA), and riboswitches,
are known to regulate aspects of epigenetic modifications.

Chromatin structure can also be modified by non-covalent mechanisms; this process is generally
referred to as chromatin remodeling. Chromatin remodeling involves repositioning of
nucleosomes, this is mediated by a group of enzymes related to as chromatin remodeling enzymes.
These enzymes utilize the energy from ATP hydrolysis to remove, reposition, and restructure the
nucleosomes. The SWI/SNF chromatin remodeling complexes are one family of multisubunit
chromatin remodeling complexes. These complexes are conserved among species and serve
essential roles in DNA repair, apoptosis, cell differentiation and others (Côté et al, 1994).

SWI/SNF chromatin remodeling complex subunits or BRG1 associated factor (BAFs) have been
revealed their functions and essential roles in many studies. BAFs direct the complex and regulate
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its remodeling activities (Workman and Kingston, 1998). Studies have shown that deletions of
SWI/SNF subunits can lead to preimplantation lethality. Deletion studies in mice have shown
that knockout mice that the lack of specific SWI/SNF subunits can also affect differentiated cells
(e.g., neurons, hematopoietic cells, and germ cells) (Chi et al., 2003; Griffin et al., 2008; Wang et
al., 2012). Mutations that inactivate or down regulate SWI/SNF subunits are found in many tumor
cells; they are therefore considered necessary to prevent tumor formation (Hohmann and Vakoc,
2014). Rhabdoid tumor is an aggressive pediatric malignancy that arises in the kidney, brain, and
soft tissues; Rhabdoid tumor is related to complete loss of SNF5/SMARCB1. Studies show that
the SWI/SNF complexes can directly interact with c-MYC, a multifunctional, nuclear
phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation.
This up-regulated oncogene is found in tumor cells; it has also been shown to cooperate with P53
pathway to regulate VEGFR2 in breast cancer cells (Pfister et al, 2015; Wang et al, 2014)

AT-rich interactive domain-containing protein 1A (ARID1A) and ARID2 are two large, mutually
exclusive BAF subunits found in SWI/SNF complexes (Lemon et al, 2001). The expression levels
of ARID1A, ARID1B, and SNF2/SMARCA2 are upregulated in rhesus monkey blastocyst stage
embryos, which suggests that these subunits are related to cell linage commitment (Zheng et al,
2004). ARID1A cooperates with elongin C, cullin 2, and Roc1 to form an E3 ubiquitin ligase,
which becomes an adapter for lysine 120 of histone 2B (H2B K120) to be remodeled by the
SWI/SNF complex (Xi et al, 2008). ARID1A also plays a role in the pluripotency of ES cells in
mice; ARID1A knockout mice fail to finish gastrulation (Wang et al, 2004; Gao et al, 2008; Li et
al, 2010).
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Bromodomain-containing protein 7 (BRD7) is ubiquitously expressed in many tissues, including
liver, brain, heart, and reproductive tracts. Studies have shown that BRD7 plays roles in inhibition
of cell cycle and cellular growth by several protein kinase pathways (Zhou et al, 2004).
Accumulating studies also indicate that BRD7 is involved in human cancers. The expression of
BRD7 is downregulated in many cancers which includes nasopharyngeal carcinoma and breast
cancer (Chiu et al. 2014). In terms of embryonic development, BRD7 is also investigated in
heterozygous BRD7 whole body knockout (KO) mouse model. Homozygous BRD7 whole body
KO mice are embryonic lethal during gestation development (Kim et al. 2016).

The aim of this study was to justify that in vitro embryo manipulations had influences on SWI/SNF
subunits which had the potential to disrupt the epigenetic state and therefore reduced
developmental potential of in vitro embryos. Our first objective was to localize ARID1A, ARID2,
BRD7, and SNF5. We hypothesized that there are differences in terms of localization or abundance
of BAFs in embryos produced in vivo and in vitro. To test our hypothesis, we have employed
immunocytochemistry staining and localized these BAFs in different stages of porcine embryos
and oocytes. The data indicated that the intracellular localization of ARID1A, ARID2 and SNF5
became possessively more nuclear as the development progressed.
3.3 Materials and Methods
Oocyte collection
All chemicals were obtained from Sigma Chemical Company (St. Louis, MO) unless stated
otherwise. Porcine (Sus scrofa) ovaries of prepubertal gilts were collected from a local abattoir,
rinsed in 37°C saline, and transported to the laboratory in an insulated container. Cumulus-oocytecomplexes (COCs) and follicular fluid were manually aspirated from antral follicles that were 3–
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5 mm in diameter. Follicular fluid containing the COCs was held at 39 °C and allowed to settle
by gravity. COCs were resuspended in HEPES-buffered medium containing 0.01% polyvinyl
alcohol (PVA) (Abeydeera et al. 1998). COCs with multiple layers of intact cumulus cells were
selected for the experiments. For germinal vesicle (GV)-stage oocytes used in PCR studies and
microinjection, COCs were vortexed in 0.1% hyaluronidase in HEPES-buffered medium for 9
minutes to remove the cumulus cells.

In vitro maturation
COCs (90-120) were matured in 500 µl of tissue culture medium 199 (TCM-199; Gibco BRL,
Grand island, NY) containing 0.14% PVA, 10 ng/ml epidermal growth factor, 0.57 mM cysteine,
0.5 IU/ml porcine FSH, and 0.5 IU/ml porcine LH. COCs were matured for 42 hours at 39°C and
5% CO2 in air, 100% humidity (Abeydeera et al. 1998). Matured COCs were then vortexed in
0.1% hyaluronidase in HEPES-buffered medium containing 0.01% PVA for 4 minutes to remove
the cumulus cells.

In vitro fertilization and embryo culture
Thirty matured and denuded oocytes were placed in 100 µl of modified Tris-buffered medium
(mTBM) and fertilized following an established protocol (Abeydeera et al. 1997), using fresh,
extended boar semen. Briefly, boar semen was collected from the Purdue Animal Sciences
Research and Education Center and extended in Modena Boar Semen Extender (Swine Genetics
International, USA) and stored at 17.5°C for up to three days. Before fertilization, 1 ml of extended
semen was mixed with 9 ml Dulbecco’s Phosphate Buffered Saline containing 1 mg/ml BSA
(DPBS) and centrifuged at 1000xg, 25°C, for four minutes; sperm washing was repeated a total of
three times.

After three washes, the sperm pellet was resuspended in mTBM and added to
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oocytes at a final concentration of 5×105 spermatozoa/ml; gametes were co-incubated for 5 hours
at 39°C and 5% CO2. Embryos were cultured in Porcine Zygote Medium 3 (PZM3) supplemented
with 3 mg/ml fatty acid-free BSA (Yoshioka et al. 2002) at 39°C, 5% CO2 and 100% humidity for
12 hours, 48 hours and 7 days in order to collect pronuclear, 4-cell and blastocyst stage embryos,
respectfully.

Once

oocytes

and

embryos

were

harvested,

they

were

subjects

to

immunocytochemical staining.

In vivo embryo flushing and collecting
Pig reproductive tracts were obtained from Purdue Meats Laboratory. Uterine horns were flushed
with HEPES-buffered medium containing 0.01% polyvinyl alcohol (PVA). Embryos were
processed to immunocytochemical staining.

Immunocytochemical staining
Porcine embryos and oocytes were fixed in 3.7% paraformaldehyde at 4°C for 1 hour. Fixed
embryos and oocytes were washed three times in phosphate-buffered saline (PBS) containing 0.1%
Tween-20 (PBST), 15 minutes for each wash. Embryos were permeabilized in 1% Triton X-100
in PBS for 1 hour and incubated in blocking solution (0.1 M glycine, 1% goat serum, 0.01% Triton
X-100, 1% powdered nonfat dry milk, 0.5% BSA and 0.02% sodium azide in PBS) overnight (1218 hour) (Prather and Rickords 1992). Embryos then were subjected to incubation with primary
antibody against ARID1A (Abcam, Cambridge, MA, USA, cat# ab182560), SNF5 (cat# ab12167),
ARID2 (cat# ab113283), and BRD7 (cat# ab56036) diluted 1: 500 in PBST at 4°C overnight.
Embryos were then washed three times in PBST (15 min per wash) and subsequently incubated
with secondary antibody (goat-anti-rabbit-IgG, FITC-conjugated, 1:500) in PBST at 4°C overnight.
After three 15-min washes in PBST, all embryos were subsequently stained with Hoechst 33342
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(5 µg/ml) for 20 minutes and mounted on slides in Vectashield (Vector Laboratories, Inc.,
Burlingame, CA, USA) solution;+ slides were sealed with nail polish. Samples were examined by
a confocal microscope (inverted Nikon A1R_MP (multi-photon microscope) including de-scanned
detectors and laser lines at 408 nm (Hoechst)and 488 nm (FITC).
3.4 Results
ARID1A intracellular localization patterns
ARID1A was evenly distributed between nuclear and cytoplasmic compartments in GV-stage
oocytes and pronuclear stage embryos (n=14/14 and n=13/13 for GV and pronuclear respectively)
(Fig. 4A and 4B); ARID1A was found to have a strong nuclear localization in 4-cell stage embryos
produced in vitro (n=14/14) (Fig. 4C). In vivo derived 4-cell embryos, the majority (4/6) showed
weak perinuclear and nuclear localization (Fig. 4D). Both in vitro and in vivo blastocysts had
predominantly nuclear localization (n=15/15, 5/5 respectively) (Fig. 4E and 4F).

ARID2 intracellular localization patterns
ARID2 was found to be tightly associated with chromatin in GV-stage oocytes (n=13/18)( Fig.
5A); ARID2 had weak nuclear localization in pronuclear embryos (9/13)( Fig. 5B) and was found
to be predominately in the nuclei of 4-cell and blastocyst stage embryos in both in vitro and in vivo
derived embryos (n=10/14 and n=13/13, n= 6/6, n= 4/4 for in vitro 4-cell (Fig. 5C), in vitro
blastocyst (Fig. 5E), in vivo derived 4-cell (Fig. 5D), and in vivo derived blastocyst,
respectively(Fig. 5F)).
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SNF5 intracellular localization patterns
SNF5 was detected in both nuclear and cytoplasmic compartments in GV-stage oocytes
(11/12)(Fig. 6A), and had perinuclear localization and nuclear staining in pronuclear stage
embryos (n=12/13)(Fig. 6B). SNF5 adopted a clear nuclear localization in the nuclei of 4-cell and
blastocyst stage embryos, both in vitro and in vivo derived embryos (n=12/13, n=11/11, n=12/14,
n= 6/6, and n= 5/5 for in vitro 4-cell (Fig. 6C), in vitro blastocyst (Fig. 6E), in vivo derived 4-cell
(Fig. 6D), and in vivo derived blastocyst, respectively (Fig. 6F))

BRD7 intracellular localization patterns
The distribution of BRD7 was variable in GV-stage oocytes. While half portion of GV-stage
oocytes appeared to have a cytoplasmic enrichment of BRD7 (n=6/11) (Fig. 7A), BRD7 adopted
a pronounced nuclear localization in the remaining GV-stage oocytes (n=5/11). BRD7 was also
variable in pronuclear stage embryos. While some pronuclear stage embryos accumulated BRD7
in their nuclei (n=6/10) (Fig. 7B), other pronuclear stage embryos possessed an even distribution
between the nucleus and cytoplasm (n=4/10).

BRD7 was found to adopt a cytoplasmic

localization in 4-cell stage in both in vitro and in vivo derived embryos (11/12, 5/6, respectively)
(Fig. 7C and 7D). At the blastocyst stage, both in vitro produced embryos (14/17) and in vivo
derived embryos (3/5) showed cytoplasmic localization of BRD7 with some nuclei had BRD7
occupied (Fig. 7E and 7F).
3.5 Discussion
Mammalian embryos undergo a dramatic amount of epigenetic remodeling during cleavage
development that can have a profound impact on both gene transcription and overall embryo
developmental competence. Epigenetic remodeling mediated by the SWI/SNF family of chromatin
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remodeling complexes is one of the key non-covalent chromatin modification. Little is known
about the unique and specific SWI/SNF complexes that exist in cleavage stage embryos. Studies
have shown these SWI/SNF complexes affect pivotal events during embryogenesis, such as
zygotic genome activation and trophectoderm differentiation (Bultman et al, 2006; Wang et al,
2010). Determining the intracellular localization patterns of BAFs is central to understanding how
which SWI/SNF complexes exist in cells at a given stage of development and therefore indicate
which epigenetic modifications are established and remodeled during this critical developmental
window (Okada and Yamaguchi, 2017).

SNF5, AT-rich interactive domain-containing protein1A and 2 (ARID1A and ARID2) are highly
associated with cell cycle regulation and cell pluripotency (Kwon et al, 1994). SNF5 has been
reported promote binding of SWI/SNF chromatin remodeling complexes to nucleosomal DNA and
enhance the remodeling activities. SNF5 is also involved in gene regulation and cell pluripotency.
Loss of SNF5 alters the structure and function of SWI/SNF complexes. Studies show that ARID1A
participates in the repair of DNA double strand breaks and cell cycle check points (Watanabe et al,
2014).

In terms of cell proliferation and differentiation, ARID1A expression modulates the

SWI/SNF complex occupancy at specific loci of gene regulatory regions for cell differentiation,
such as P19 in cardiac cells (Lei et al, 2012).

According to our results, SNF5, ARID1A and ARID2 have similar localization patterns during
cleavage development. They are largely evenly distributed between the nucleus and cytoplasm in
GV stage oocytes and predominately localized in nuclei after the 4-cell stage embryo of
development. This localization reveals the suggested functions of SNF, ARID1A and ARID2.
Zygotic transcription begins at the 4-cell stage in porcine embryos. Prior to that time the embryo
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relies on maternal mRNA and proteins to control the first few cell divisions (Flach et al, 1982).
ZGA has been considered a landmark event during preimplantation embryo development.
Epigenetic marks are remodeled on a global scale during this transition. The nuclear localization
of these BAFs also suggests a role during the blastocyst stage, a stage of development characterized
by a massive cell proliferation and cell differentiation. BRD7 shows a different localization pattern
in preimplantation porcine embryos. Studies suggest BRD7 plays roles in inhibition of cell cycle
and cellular growth by several protein kinase pathways (Zhou et al, 2004). The predominantly
cytoplasmic BRD7 localization after 4-cell stage embryos could be rationalized since cell cycle
activity is significantly increasing during morula formation.

Our results show there are no significant differences in localization or abundance of SNF5, BRD7,
ARID1A and ARID2 in embryos produced in vivo and in vitro. These results suggest that the
collection of SWI/SNF complexes may change during progression from GV-stage oocyte to
blastocyst stage embryo. Understanding which SWI/SNF subunits have access to the nucleus will
provide insight into which chromatin remodeling complexes can function at discrete stages of
development.

Such information will enable us to determine how transcription of particular

networks of genes may be altered under various conditions that perturb the localization of discrete
SWI/SNF complexes.
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CHAPTER 4: CONCLUSIONS

Cell proliferation and cell differentiation are key events during embryogenesis and must be tightly
controlled and regulated. Cells of the very early mammalian embryo all have the potential to form
any of the cells of the body, a trait referred to as pluripotency. Epigenetic modifications are required
for these pluripotent embryonic stem cells to commit into specific cell lineages. It is now
recognized that there are two peak periods of epigenetic remodeling during embryogenesis, one
during cleavage development and the second during germ cell formation.

Chromatin remodeling is a way to change the epigenetic state to control gene expression. SWI/SNF
chromatin remodeling complexes are large, multi-protein complexes with an SNF2-type ATPase
as catalytic core. They utilize the energy from ATP hydrolysis to reposition nucleosomes on a
chromatin template. The process results in decondensed nucleosomes and allows access of
transcriptional machinery genomic DNA. Studies have suggested that epigenetic errors can have
profound impacts on animal development. It has been reported that animals produced by ART are
at an increased risk for developing diseases that have an epigenetic basis.

SWI/SNF chromatin remodeling complexes are the major target in my studies. Several SWI/SNF
subunits have been reported to directly or indirectly interact with pluripotent genes in mouse. Sox2,
Oct4, Nanog and c-Myc are examples; they are involved in cell cycle and cell proliferation during
early stages of embryo development. Our laboratory uses the porcine embryo as our model.

The

size of porcine embryos is similar with that of human embryos and follow a similar developmental
timeline. Both species have the zygotic genome activation happened during the 4-cell stage and
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embryos reaching the blastocyst stage six days after fertilization. Using the porcine embryo as our
models provides us the better opportunity to scope the human embryo development and to study
complex human diseases in a physiologically relevant context.

In my studies, we have concluded that ARID1A is required for early embryo development.
ARID1A knockdown embryos arrest at the 4-cell stage. Coupling this result with the nuclear
localization pattern of ARID1A at 4-cell stage, the crucial role of ARID1A played during early
embryo development is revealed. There are several potential extensions of my study which
includes how ARID1A activates or inactivates certain pluripotent gene expression and how
ARID1A changes its intracellular localization during embryo development. Besides studying
ARID1A along, the interaction of ARID1A and other BAFs is also a potential direction for us to
investigate.

The study of understanding the function of BAFs and how SWI/SNF chromatin remodeling
complexes is mediated during preimplantation development will provide us insight into how in
vitro embryo manipulation perturb epigenetic status of embryos during the early developmental
timeframe. Although no significant difference was found between the intracellular localization
patterns of SNF5, BRD7, ARID1A and ARID2, the effect of in vitro manipulation can be minor
and we may not have been able to determine subtle changes in BAFs localization with our assays.
A more sensitive approach may be required. Our results suggest that selected BAFs have different
intracellular localization patterns over the development time-course and the composition of
SWI/SNF chromatin remodeling complexes may change as development proceeds.
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Assisted reproductive technologies are routinly used in domestic animals, endangered species and
humans to preserve germ line and address infertility. Understanding the components of SWI/SNF
chromatin remodeling complexes is critical to developing new and novel tools to overcome the
compromised development associated with in vitro embryo manipulation and improve
reproductive efficiency in both humans and other animal species.
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Table 1. Knockdown of ARID1A in porcine embryos leads to reduce in vitro developmental
competence. abSuperscript letters denote statistically significant differences (P < 0.0001)
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Figure 1. ARID1A transcript levels change over the course of development from
GV-stage oocyte to blastocyst stage embryo. Fold expression was calculated by
the equation 2- △ △ Ct. The average of three independent experimental
replicates is shown. Different superscripts represent significant differences
between transcripts at discrete developmental stages after Tukey’s multiple
comparison post-test (P < 0.05).
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Figure 2. Validation of RNAi-mediated knockdown of ARID1A transcripts in
porcine oocytes. Quantitative PCR results of GV-stage oocytes 40 hours after
injection of interfering RNAs targeting ARID1A. This graph presents the fold
expression obtained from subtracting the CT value for ARID1A from the △CT
value for the housekeeping gene YWHAG and non-injection treatment. The
average of two independent experimental replicates is shown.
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Figure 3. ARID1A protein levels are reduced in embryos injected interfering
RNAs that target ARID1A. Representative immunocytochemical confocal
images of ARID1A intracellular localization in three treatment groups: ARID1A
siRNA treatment, nonsense control siRNA treatment, and non-injection control
treatment. Panels A, B, and C contain representative images of a 4-cell stage
embryo from the ARID1A siRNA treatment group; Panels D, E, and F contain
representative images of a 4-cell stage embryo from the control siRNA treatment
group; Panels G, H, and I contain representative images of a 4-cell stage embryo
from the non-injected treatment group. DNA and immunocytochemical
staining of ARID1A are shown in panels A, D, and G; DNA staining alone is
shown in panels B, E, and H; ARID1A staining is shown in panels C, F, and I.
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Figure 4. Representative images of porcine oocytes/embryos analyzed by ICC
using antibodies for ARID1A and FITC-conjugated secondary antibodies, as well
as Hoechst staining to confirm localization of nuclei. A) GV oocyte, B) PN stage,
C) INF 4-cell stage, D) in vivo 4-cell stage, E) IVF blastocyst stage, F) in vivo
blastocyst stage.
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Figure 5. Representative images of porcine oocytes/embryos analyzed by ICC using
antibodies for ARID2 and FITC-conjugated secondary antibodies, as well as Hoechst
staining to confirm localization of nuclei. A) GV oocyte, B) PN stage, C) INF 4-cell
stage, D) in vivo 4-cell stage, E) IVF blastocyst stage, F) in vivo blastocyst stage.
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Figure 6. Representative images of porcine oocytes/embryos analyzed by ICC using
antibodies for SNF5 and FITC-conjugated secondary antibodies, as well as Hoechst
staining to confirm localization of nuclei. A) GV oocyte, B) PN stage, C) INF 4-cell
stage, D) in vivo 4-cell stage, E) IVF blastocyst stage, F) in vivo blastocyst stage.

66

Figure 7. Representative images of porcine oocytes/embryos analyzed by ICC using
antibodies for BRD7 and FITC-conjugated secondary antibodies, as well as Hoechst
staining to confirm localization of nuclei. A) GV oocyte, B) PN stage, C) INF 4-cell
stage, D) in vivo 4-cell stage, E) IVF blastocyst stage, F) in vivo blastocyst stage.

